To identify correlates of return to work for employed breast cancer survivors.
INTRODUCTION
Employed women with breast cancer face several challenges as they recover from treatment and attempt to return to the workplace. [1] [2] [3] [4] [5] Despite these challenges, many breast cancer survivors are able to return to work and maintain their prediagnosis level of employment and income. 6 The literature suggests that demographic characteristics, 2,7-9 health status, 3,10-16 treatment, 17-20 and physical job tasks 21, 22 influence return to work for breast cancer patients, but little is known about the employer's role. The employer might have a major influence on return to work because of employment benefits, job type or tasks, and/or workplace accommodation. [23] [24] [25] [26] Using multivariate analysis, we studied several different factors to identify correlates associated with return to work for breast cancer survivors. The purpose of this research was to examine the impact of demographic, clinical, and employment characteristics on return to work for newly diagnosed breast cancer patients.
PATIENTS AND METHODS
Employed, English-speaking women ages 30 to 64 years with a first, primary diagnosis of breast cancer were identified from the Metropolitan Detroit Cancer Surveillance System (Detroit, MI), which is a participant in the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program. In our sample, the earliest diagnosis month and year was June 2001, and the latest diagnosis month and year was April 2002. We enrolled 443 women who were working 3 months before their breast cancer diagnosis. Women were ineligible for the study if they had a previous cancer or lived outside of Wayne, Macomb, and Oakland counties. Eligible patients were offered a $25 incentive payment to complete all interviews. This study was part of a larger study that had a participation rate of 83% for patients who were screened and determined to be eligible. 27 The retention rate was 94% at 12 months and 92% at 18 months. The Institutional Review Board of Michigan State University (East Lansing, MI) approved this study. All patients provided written informed consent.
Four hundred sixteen enrollees participated in an interview that collected data referring to 3 months before the breast cancer diagnosis and an interview that occurred 12 months after breast cancer diagnosis (Fig 1) . The recruitment and enrollment procedures have been explained by Bradley et al. 27 Four hundred seven enrollees also participated in an interview 18 months after the breast cancer diagnosis. All phases of patient ascertainment, including case abstraction, physician notification, participant mailings, and screening, occurred simultaneously. The target sample size was 500 breast cancer patients. Once this was achieved, study enrollment was discontinued. Thus, there were 38 patients who were not screened because accrual was complete and 13 patients who were eligible but excluded because accrual was complete.
As depicted in Figure 1 , we were unable to contact 169 women, and an additional 163 women refused to participate in the study before they were screened for eligibility. To address issues of potential sample bias, we extracted demographic and clinical data from the SEER registry for all potentially eligible cancer patients. Enrolled women were compared in terms of age, race, and stage at diagnosis to women we were unable to contact and women who refused participation after having been determined as eligible for the study. In addition, we extracted demographic and socioeconomic variables that are predictive of individual socioeconomic status and health outcomes from 2000 census block data. Patients we were unable to contact resided in census tracts with a higher percentage of households living in poverty and lived in block groups with a greater percentage of household incomes less than $20,000 (21% to 23%) compared with the residents in census blocks where the enrolled patients resided (13% to 15%). In addition, those patients who refused participation resided in census blocks where the employment rate was low relative to the employment rate in census blocks where participants resided.
27 Given these findings, it is possible that women employed in lower paying jobs had a more difficult return to work experience than women in our sample.
Data Collection
Patients were interviewed by telephone. The surveys collected data on their demographic characteristics, employment status, health status, comorbidity, job tasks, and job benefits. In addition, patients were asked if they agreed with statements regarding their employer accommodation for cancer treatment needs and regarding employer discrimination against them because of their cancer. Data on cancer stage and treatment were extracted from the SEER registry.
Study Variables
The main outcome for this study was return to work 12 and 18 months after a breast cancer diagnosis. Return to work was defined according to a patient's positive response to the question, "Are you currently working?" We chose return to work as the primary outcome because we considered it a measure of recovery for breast cancer survivors. Figure 2 depicts a model of the possible effects of demographic, clinical, and job characteristics on a breast cancer patient's return to work. Clinical variables included cancer summary stage and first cancer-directed treatment abstracted from the SEER registry supplemented by patients' reports, comorbidity using a modified Charlson index 28 with each comorbid condition equal to one (high comorbidity Ն three comorbid conditions), and self-reported health status (ie, excellent, very good, good, fair, or poor) before diagnosis. Employment variables included type of occupation, full-time employment, self-employment, presence or absence of sick leave and health insurance, job involvement, job tasks (heavy lifting and data analysis), perceived employer accommodation, and perceived employer discrimination.
We asked patients questions about job tasks including heavy lifting and data analysis. Responses to heavy lifting and data analysis questions were ordinal (all/almost all of the time, most of the time, some of the time, or none/almost none of the time) and from the patient's point of view. The heavy lifting and data analysis questions were extracted from the Health and Retirement Study, which has been widely used. 29 We inquired about job involvement using a modification of the job involvement scale developed by Lodahl and Kejner. 30 A minimum job involvement score was 5, and a maximum score was 20. In the analysis, the job involvement score was dichotomized to high (Ն 15) and low. We also inquired about the perceived social support environment of the workplace by asking whether the employer was accommodating to the patient's cancer and need for treatment (strongly agree, agree, disagree, or strongly disagree). In addition, we asked whether the employer discriminated against the patient because of the breast cancer diagnosis (strongly agree, agree, disagree, or strongly disagree). In the reported analysis, the responses for the job characteristics were dichotomized to reflect high or low activity and agreement or disagreement.
Statistical Analysis
Univariate analyses included t tests for continuous variables and 2 tests for categoric variables. Variables with a statistically significant difference of P Յ .05 in the univariate analysis were included in the multivariate logistic regression analysis, and some demographic and treatment variables were included as control variables. For the multivariate analysis, clinical variables included self-reported health status (dichotomized as poor or fair health v good, very good, or excellent health), mastectomy (yes v no), receipt of radiation therapy, receipt of chemotherapy, and cancer stage. There were only nine patients with metastatic breast cancer, which was too few to allow for separate statistical analysis of distant stage. Thus, regional and distant stages were combined. With return to work as the dependent variable, we used logistic regression to identify independent variables associated with return to work 12 and 18 months after a breast cancer diagnosis. The STATA statistical program version 7.0 (STATA Corp, College Station, TX) was used for all analyses. Table 1 lists the characteristics of the participants. The mean age at the time of diagnosis was 50.8 years, and patients had a mean household income of $46,800. Twenty percent of the women were black, most were married, and more than 70% had some college or a college degree. At baseline, most women reported good to excellent health, but compared with white women, black women were more likely to report fair or poor health (P ϭ .024), and more had advanced, regional disease (P ϭ .016). The most common stage of disease was local followed by regional, in situ, and distant (2.2%). Less than half of patients had a mastectomy, but more than half received radiation and chemotherapy. Most women were employed full time with white collar positions, and few were self-employed. Women were employed in managerial/professional positions (35%) followed by technical/ sales/administrative jobs (26%), service positions (24%), operators/ fabricators/laborers jobs (4%), precision production/craft/repair jobs (1%), and other jobs (10%). Half of the patients reported data analysis as a job task, and few women reported heavy lifting as a job task (11%). A high percentage of women (87%) perceived that their employer was accommodating to their illness and need for treatment, and few women perceived that they were discriminated against because of their cancer diagnosis (7%). Every woman who returned to work returned to her same position of employment. At 12 months after breast cancer diagnosis, 18% of patients were not working, and at 18 months, 17% were not working. There were 341 women who returned to work at 12 months, and 26 (7.6%) of these women were not working at 18 months (Fig 3) .
RESULTS
In the 12-month univariate analysis, factors associated with a lower likelihood of return to work were lower annual household income, less than high school education, fair/poor health status before diagnosis, advanced-stage tumors, blue collar occupation, heavy lifting required by the job, and perceived employer discrimination related to the cancer diagnosis (Table 2) . However, college graduation, Yes  27  6  19  5  No  386  94  388  95  Total  413  100  407  100  Cancer stage  In situ  108  26  107  26  Local  175  42  171  42  Regional/distant  120  29  116  29  Unknown  13  3  13  3  Total  416  100  407  100  Mastectomy  Yes  181  44  176  43  No  235  56  231  57  Total  416  100  407  100  Radiation therapy  Yes  232  56  227  56  No  184  44  180  44  Total  416  100  407  100  Chemotherapy  Yes  242  58  234  58  No  174  42  173  42  Total  416  100  407  100  Fulltime employee  Yes  320  77  313  77  No  96  23  94  23  Total  416  100  407  100  Self-employed  Yes  45  11  44  11  No  370  89  362  89  Total  415  100  406  100 (continued on following page)
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www.jco.orgin situ cancer stage, having sick leave, white collar occupation, and perceived employer accommodation for cancer illness and treatment needs were associated with a greater likelihood of return to work. At 18 months after diagnosis, older age, black race, less than high school education, and fair/poor health status were associated with a lower likelihood of return to work, whereas in situ stage and perceived employer accommodation were associated with a greater likelihood of return to work. Table 3 lists the logistic regression analysis results for return to work at 12 months. Women who perceived that their employer was accommodating for their illness or cancer treatment were more likely to return to work (odds ratio ϭ 2.2; 95% CI, 1.03 to 4.8). However, women who had fair/poor health status before diagnosis (odds ratio ϭ 0.31; 95% CI, 0.14 to 0.73), advanced tumors (odds ratio ϭ 0.23; 95% CI, 0.08 to 0.65), jobs that involved heavy lifting (odds ratio ϭ 0.42; 95% CI, 0.18 to 0.99), or perceived employer discrimination because of the cancer diagnosis (odds ratio ϭ 0.27; 95% CI, 0.10 to 0.71) were less likely to return to work. Table 3 also shows the same model with return to work at 18 months as the outcome. Patients who perceived that their employer was accommodating were again more likely to return to work (odds ratio ϭ 2.3; 95% CI, 1.06 to 5.1). Patients with older age (odds ratio ϭ 0.95; 95% CI, 0.91 to 0.99), black race (odds ratio ϭ 0.35; 95% CI, 0.18 to 0.68), or fair/poor health status 3 months before diagnosis (odds ratio ϭ 0.33; 95% CI, 0.14 to 0.77) were less likely to return to work.
DISCUSSION
In this study, a high proportion of patients reported that their employer was accommodating, which suggests that most employers were sensitive to the health needs of their employees with breast cancer. More than 89% of the patients in this study qualified for accommodations according to the Americans with Disabilities Act because they worked for employers with 15 or more employees. The Americans with Disabilities Act and its impact on working cancer survivors has been comprehensively reviewed by Hoffman. 31 The perceived willingness of the employer to accommodate their workers' illness and treatment needs was an important factor for return to work. This finding has implications for employers and recovering breast cancer employees, and, to our knowledge, this is the first time this result has been reported. In a review, Spelten et al 24 concluded that a supportive work environment seemed to facilitate return to work and that more systematic research was needed. Chirikos et al 7 reported that 41% of breast cancer patients expressed a need for special accommodations to keep working but did not link employer accommodation to return to work as an outcome. Greenwald et al 32 found that return to work was positively associated with a cancer employee's ability to control the number of hours worked and amount of work, but this study did not include breast cancer patients. 
‫ء‬
Patients reported data as it existed 3 months before cancer diagnosis for age, income, race, education, marital status, children at home, health status, sick leave, employment type, and health insurance. Cancer stage was reported at time of diagnosis. Other variables are from data collected 12 or 18 months after breast cancer diagnosis.
†Does not equal 100% because of rounding. ‡Three or more comorbid conditions. §Forty-one patients at 12 months and 40 patients at 18 months did not specify job type. Total job involvement score Ն 15. ¶As perceived by patient. In situ  98  91  10  9  108  100  97  91  10  9  107  100  Local  144  82  31  18  175  100  139  81  32  19  171  100  Regional/distant  89  74  31  26  120  100  92  79  24  21  116  100  Unknown  10  77  3  23  13  100  8  62  5  38  13  100  Mastectomy  Yes  150  83  31  17  181  100  146  83  30  17  176  100  No  191  81  44  19  235  100  190  82  41  18  231  100  Radiation therapy  Yes  187  81  45  19  232  100  190  84  37  16  227  100  No  154  84  30  16  184  100  146  81  34  19  180  100  Chemotherapy  Yes  195  81  47  19  242  100  189  81  45  19  234  100  No  146  84  28  16  174  100  147  85  26  15  173  100  Fulltime employee  Yes  265  83  55  17  320  100  260  83  53  17  313  100  No  76  79  20  21  96  100  76  81  18  19  94  100  Self-employed  Yes  36  80  9  20  45  100  37  84  7  16  44  100  No  304  82  66  18  370  100  298  82  64  18  362  100  Health insurance  Yes  327  82  71  18  398  100  322  83  67  17  389  100  No  14  78  4  22  18  100  14  78  4  22  18  100  Sick leave  Yes  228  85  39  15  267  100  221  84  41  16  262  100  No  113  76  36  24  149  100  115  79  30  21  145  100  Job type  White collar  215  86  35  14  250  100  205  83  42  17  247  100  Blue collar  93  74  32  26  125  100  96  82  24  18  120  100  High job involvement † †  Yes  59  82  13  18  72  100  60  83  12  17  72  100  No  282  83  59  17  341  100  274  82  58  18  332  100 (continued on following page)
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Few women (7%) reported problems with discrimination because of cancer, suggesting that this was not a widespread problem for breast cancer patients in our sample. However, women who reported that they had been discriminated against because of their cancer were significantly less likely to return to work at 12 months. Other investigators have reported some or no employment effects of perceived employer discrimination as a result of illness.
33, 34 The manifestations of perceived job discrimination attributable to illness and need for treatment warrants further investigation.
Our study of the impact of demographic and clinical characteristics on breast cancer patients' return to work yielded results similar to other research. 1, 5, [11] [12] [13] [14] [15] 21, 23, 35 Compared with younger patients, older patients were less likely to return to work at 18 months. We would expect age to be associated with retirement, although it is not mandatory in the United States. In addition, black race, low health status, and advanced tumor stage negatively affected return to work for breast cancer patients. In some studies, white collar workers were more likely to return to work and receive accommodations when compared with their counterparts. [36] [37] [38] We controlled for white collar/blue collar job type in our multivariate analysis and found that, although job type was not statistically significant, heavy lifting as a job task was statistically significantly associated with a lower likelihood of return to work. Data analysis as a job task was not statistically significantly associated with return to work. Chemotherapy had no effect on return to work, and this finding is consistent with the research of other investigators who reported no effect of chemotherapy on return to work or long-term quality of life for breast cancer survivors.
19,39-41
There was some variation between the 12-and 18-month assessments of return to work, and some of the difference was a result of a core of women moving in and out of the workforce. We found no distinguishing characteristics of these women to explain their movement in and out of the workforce. Some of the variation between the 12-and 18-month assessments may be attributable to reduction in treatment-related symptoms and employer adaptation to the patient's health condition.
A strength of this study is its prospective, longitudinal design. Bushunow et al 19 studied return to work of breast cancer patients at 1, 3, 6, and 12 months, but this study was retrospective and focused only on the effect of chemotherapy. Other studies have been cross sectional and not designed to account for differences over time. 21, 42 The sample includes a sizeable minority population, which is absent from some other studies.
Several limitations are noted. First, the study sample from the Detroit metropolitan area may not be representative of breast cancer survivors from other parts of the country, especially those residing in rural areas. Our study sample was restricted to employed women, thus they were younger and in better health relative to the population of women diagnosed with breast cancer. In addition, our own analyses indicated that women from poorer areas or with less well-paying jobs may have been under-represented in our sample. Second, we lacked extensive clinical information normally found in a medical record audit. Data were either absent or inconsistently reported for axillary node dissections, disease recurrence, and initiation of hormone therapy, all of which might affect return to work. Third, questions regarding job tasks, accommodation, and discrimination were subject to patient interpretation. The interviewers did not provide definitions of the job tasks, and patients may have interpreted their job responsibilities differently. We did not validate attempts or denial of accommodation by visiting the workplace. Yes  29  66  15  34  44  100  32  76  10  24  42  100  No  312  84  60  16  372  100  304  83  61  17  365  100  Data analysis  Yes  176  85  31  15  207  100  173  84  32  16  205  100  No  165  79  44  21  209  100  163  81  39  19  202 
‫ء‬
Patients reported data as it existed 3 months before cancer diagnosis for age, income, race, education, marital status, children at home, health status, sick leave, employment type, and health insurance. Cancer stage was reported at time of diagnosis. Other variables from data collected 12 or 18 months after breast cancer diagnosis. Group comparisons made using 2 test. †Significant difference for 18-month RTW and no RTW between-group comparisons at P Յ .05. ‡Significant difference for 12-month RTW and no RTW between-group comparisons at P Յ .01. §Significant difference for 18-month RTW and no RTW between-group comparisons at P Յ .001. Significant difference for 12-month RTW and no RTW between-group comparisons at P Յ .05.
¶Significant difference for 18-month RTW and no RTW between-group comparisons at P Յ .01. #Three or more comorbid conditions. ‫ءء‬Significant difference for 12-month RTW and no RTW between-group comparisons for P Յ .001. † †Total job involvement score Ն 15. ‡ ‡As perceived by patient.
Emotional readiness and other psychosocial variables may play an important role in a woman's decision to return to work, but we did not assess patients' feelings about work re-entry. It is possible that workers may use lack of accommodation to justify their decision to quit work or workers may legitimately feel disenfranchised by their employers. Further research is warranted to assess patient and employer understanding of workplace accommodation and to assess the accuracy of patient reports regarding accommodation. Likewise, we neither determined whether discrimination actually occurred nor asked women to explain what they meant by accommodation or discrimination or to provide examples. Nevertheless, the employee's perception of discrimination reflects an impression of a negative job environment, which could possibly be a barrier for job return.
Recurrent disease, which was not measured by our study, might influence a woman's desire and/or ability to return to work. However, we suspect that this problem had little impact on our results because there were only nine patients with metastatic disease and other investigators have reported low rates of recurrence within 18 months of a breast cancer diagnosis. [43] [44] [45] This study highlights the importance of the employer's role in the recovery of employed breast cancer patients. In addition to good health and early tumor stage, workplace accommodation as perceived by the employee is a key factor that increases the likelihood of return to work. Our findings suggest that employer sensitivity and response to their employee's cancer illness and treatment needs will facilitate the return of valuable workers to the workplace. Breast cancer patients can be encouraged to know that when they return to work they are likely to find a workplace environment that is willing to help them adapt to the challenges they face from their illness. 
